# Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME

> **NCT03690947** · PHASE4 · COMPLETED · sponsor: **Beijing Hospital** · enrollment: 72 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Intravitreal Ranibizumab
- **PROCEDURE:** Micropulse Laser
- **DRUG:** Intravitreal Ranibizumab as needed

## Key facts

- **NCT ID:** NCT03690947
- **Lead sponsor:** Beijing Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-09-30
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03690947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03690947, "Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT03690947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*